Soonchunhyang Med Sci.  2012 Dec;18(2):111-114.

Regression of Choroidal Metastasis of Non-small-cell Lung Cancer with Intravitreal Bevacizumab and Photodynamic Therapy

• Kim JW
• Lee SJ

Abstract

A 56-year-old female patient presented with decreased visual acuity in her right eye lasting for one day. During the first visit, best corrected visual acuity (BCVA) was 20/80 and 20/20, in the right and left eye, respectively. Fundus examination of the right eye revealed an elevated mass in the superior area of the optic disc and exudative retinal detachment in the macula. Choroidal metastatic tumor secondary to non-small-cell lung cancer (NSCLC) was diagnosed after systemic work up. Photodynamic therapy (PDT) and the intravitreal bevacizumab injection for choroidal metastatic carcinoma were performed. After six months, the BCVA of the right eye was improved to 20/25. Complete regression of the tumor was noticed and serous detachment was resolved. There has been no recurrence for six months. We observed that combined treatment with PDT and intravitreal bevacizumab injection is effective in BCVA improvement and tumor regression, in a patient with choroidal metastasis of NSCLC.

Keyword

Bevacizumab; Choroidal metastasis; Non-small-cell lung cancer; Photodynamic therapy

MeSH Terms

Antibodies, Monoclonal, Humanized
Choroid
Eye
Female
Humans
Lung
Lung Neoplasms
Neoplasm Metastasis
Photochemotherapy
Recurrence
Retinal Detachment
Triazenes
Visual Acuity
Bevacizumab
Antibodies, Monoclonal, Humanized
Triazenes